Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2011, Vol. 9 ›› Issue (9): 965-972.doi: 10.3736/jcim20110907

• Original Clinical Research • Previous Articles     Next Articles

Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: A randomized controlled trial

Susuana Kuek,  Wen-jun Wang(), Sui-qi Gui()   

  1. Department of Integrated Traditional Chinese and Western Medicine, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China
  • Received:2011-01-12 Accepted:2011-04-25 Online:2011-09-20 Published:2011-09-15
  • Contact: Wang Wen-jun,Gui Sui-qi E-mail:wjwwang@yahoo.com.cn;sqgui@hotmail.com

Background: Polycystic ovary syndrome (PCOS) is a complex hormonal disorder and one of the most common reproductive endocrinology abnormalities in women. Recently, many studies have been conducted assessing Chinese herbal medicine as an alternative treatment for women with PCOS, it is, therefore, worthwhile to analyze and observe the curative effects of traditional Chinese medicine treatment in PCOS.

Objective: To evaluate the efficacy of the Chinese patent medicine Tian Gui Capsule, in women with PCOS and compare its effects with metformin and ethinyl estradiol plus cyproterone acetate (Diane-35). Design, setting, participants and intervention: A total of 47 PCOS outpatients from the Obstetrics and Gynecology Hospital of Fudan University were randomly divided into 3 groups. Patients in group A (n=19) were given Tian Gui Capsule, patients in group B (n=17) were given metformin, and patients in group C (n=11) were given Diane-35. The 3 groups of patients were treated for 3 months. Main outcome measures: Serum testosterone (T), sex hormone binding globulin (SHBG) and dehydroepiandrosterone sulfate (DHEA-S) levels, free androgen index (FAI), fasting blood glucose (FPG), fasting insulin (FINS), homeostasis model assessment of insulin resistance (HOMA-IR), insulin sensitive index (ISI) and left and right ovary volumes of the 3 groups were evaluated before and after treatment

Results:After 3 months of treatment, when compared with before treatment data, group A patients showed decreased serum T and SHBG levels, FAI, FINS, and left and right ovary volumes (P<0.05), and increased serum DHEA-S (P<0.05), while the FPG level showed no significant change. Although the level of serum T and FINS among the 3 groups after the treatment were similar, group A demonstrated better results than group B in reducing the FAI and increasing the serum SHBG, but less significant results than group C besides, group B was the only group showed improved insulin sensitivity. Although the level of FPG of the 3 groups after treatment were similar, group C had the most increased FPG.

Conclusion:The effects of Tian Gui Capsule on hyperandrogenism are not as significant as Diane-35, but more effective than metformin. The effects of Tian Gui Capsule on hyperinsulinemia are not as significant as metformin but better than Diane-35. Tian Gui Capsule treats PCOS by regulating ovarian functions and reducing blood insulin level without inhibiting the function of the hypothalamic-pituitary-ovarian axis. Further studies with larger sample size are needed to confirm the above results.

Key words: polycystic ovary syndrome, Chinese patent drugs, Tian Gui Capsule metformin, ethinylestradiol and cyproterone acetate tablet, hyperandrogenism, insulin resistance, randomized controlled trials

Figure 1

Flow diagram of this clinical trial"

"

Group n Height (m) Weight (kg) BMI (kg/m2) WHR
Before After Before After Before After
A 19 1.59±0.03 59.47±8.76 58.57±8.37* 23.26±3.34 22.90±3.09* 0.83±0.04 0.82±0.08
B 17 1.58±0.05 64.55±7.77 61.46±6.90 25.70±2.96 24.61±2.87 0.83±0.05 0.82±0.05
C 11 1.58±0.02 58.86±10.66 59.04±10.18 19.27±10.46 19.45±10.46 0.83±0.07 0.82±0.08

"

Group n FSH (IU/L) LH (IU/L) E2 (pmol/L)
Before After Before After Before After
A 19 6.47±1.33 6.53±1.36 9.03±5.05 9.49±7.19 138.88±76.71 146.22±80.02*
B 17 7.54±1.98 7.14±1.59 9.79±4.88 8.48±5.22 157.16±65.02 172.26±130.10
C 11 8.27±2.64 7.08±3.39 11.40±4.00 5.45±2.74 164.48±52.77 175.82±69.00
Group n T (nmol/L) DHEA-S (μmol/L) SHBG (nmol/mL)
Before After Before After Before After
A 19 2.06±0.53 1.94±0.50* 5.52±1.94 6.25±1.86*□ 64.74±46.46 56.17±29.81*□□
B 17 2.30±0.59 1.97±0.47 6.98±2.18 7.46±2.32△□ 61.75±22.15 60.30±40.85△□□
C 11 2.19±0.80 1.63±0.43 4.57±1.89 4.19±1.43 73.15±45.22 258.02±101.00▲▲

"

Group n FPG (mmol/L) FINS (IU/L) HOMA-IR
Before After Before After Before After
A 19 4.25±0.39 4.36±0.40 11.36±7.37 10.74±6.04* 0.46±0.96 0.49±0.87
B 17 4.47±0.45 4.57±0.45 14.60±4.35 12.61±8.38△△ 1.01±0.33 0.74±0.66△△
C 11 4.28±0.36 4.65±0.26 12.01±8.81 9.99±4.51 0.64±0.60 0.51±0.56
Group n ISI FAI
Before After Before After
A 19 0.05±0.10 0.05±0.10 4.83±3.27 4.68±3.08*
B 17 0.01±0.05 0.02±0.01△△ 4.83±3.83 5.19±4.85△△
C 11 0.02±0.01 0.02±0.01 3.79±1.77 0.77±0.55▲▲

"

Group n FINS (IU/L) HOMA-IR
A 19 -0.62±5.76 0.03±0.52
B 17 -2.19±7.87 -0.29±0.61
C 11 -2.01±6.92 -0.02±0.33

"

Group n Left ovary volume Right ovary volume
Before After Before After
A 19 11.42±4.24 9.02±4.00*□ 12.17±3.71 11.79±4.41*□
B 17 10.24±4.33 9.96±4.07△□ 12.23±6.99 12.43±4.36
C 11 11.18±3.31 8.90±3.59▲▲ 13.71±5.75 10.24±4.65▲▲
[1] Wang FF, Hou LH, Li N . A review on related factors of polycystic ovary syndrome[J]. Yi Xue Yan Jiu Za Zhi, 2009,38(11):10-12
王芳芳, 侯丽辉, 李楠 . 多囊卵巢综合征发病相关因素的研究进展[J]. 医学研究杂志, 2009,38(11):10-12
[2] Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI . A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile[J]. J Clin Endocrinol Metab, 1999,84(11):4006-4011
doi: 10.1210/jcem.84.11.6148
[3] Li MZ . Diagnosis and treatment of polycystic ovary syndrome[J]. Zhonghua Fu Chan Ke Za Zhi, 2002,37(7):444-446
doi: 10.3760/j.issn:0529-567X.2002.07.029
李美芝 . 多囊卵巢综合征的诊断与治疗[J]. 中华妇产科杂志, 2002,37(7):444-446
doi: 10.3760/j.issn:0529-567X.2002.07.029
[4] Azziz R . Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature[J]. J Clin Endocrinol Metab, 2006,91(3):781-785
doi: 10.1210/jc.2005-2153
[5] Wei MJ, Yu J . Clinical observation of Tian Gui prescription in treating hyperandrogenism anovulatory patients[J]. Zhonghua Nei Fen Mi Dai Xie Za Zhi, 2001,17(2):105-106
doi: 10.3760/j.issn:1000-6699.2001.02.015
魏美娟, 俞瑾 . 天癸方治疗高雄激素无排卵症临床观察[J]. 中华内分泌代谢杂志, 2001,17(2):105-106
doi: 10.3760/j.issn:1000-6699.2001.02.015
[6] Zhou LR, Yu J . Clinical observation on treatment of hyperinsulinemia and hyperandrogenism anovulatory patients with replenishing kidney-yin drugs[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 1996,16(9):515-518
周丽蓉, 俞瑾 . 补肾阴药治疗高胰岛素高雄激素无排卵症的临床观察[J]. 中国中西医结合杂志, 1996,16(9):515-518
[7] Veith I. The Yellow Emperor’s classic of internal medicine(第2版)[M]. Selangor Darul Ehsan, Malaysia: Pelanduk Publications, 1992,( 第2版):98-99
[8] Wang XJ, Shen ZY . Treating polycystic ovary syndrome by nourishing yin and clearing fire[J]. Shanghai Zhong Yi Yao Za Zhi, 1999,33(12):22-23
王兴娟, 沈自尹 . 承师心悟——滋阴降火法治疗多囊卵巢综合征[J]. 上海中医药杂志, 1999,33(12):22-23
[9] Yu J, Sun YL, Shao GQ . Regulation of hypothalamus-pituitary-ovary function in polycystic ovary syndrome by invigorating kidney and eliminating phlegm[J]. Zhong Xi Yi Jie He Za Zhi, 1986,6(4):218-221
俞瑾, 孙月丽, 邵公权 . 补肾化痰治疗多囊卵巢综合征中对下丘脑-垂体-卵巢功能的调节[J]. 中西医结合杂志, 1986,6(4):218-221
[10] Zhang YP, Yu J, Gui SQ . Studies on the validity of the androgen sterilized rat and ovulation-inducing effect of Zi Shen Yin herbs[J]. Zhonghua Nei Fen Mi Dai Xie Za Zhi, 1994,10(2):98-101
张月萍, 俞瑾, 归绥琪 . 雄激素致不孕大鼠发病机制及滋肾阴药对其促排卵的作用[J]. 中华内分泌代谢杂志, 1994,10(2):98-101
[11] Li GH, Huang W . Application of metformin in polycystic ovary syndrome[J]. Shi Yong Fu Chan Ke Za Zhi, 2005,21(9):534-536
doi: 10.3969/j.issn.1003-6946.2005.09.009
李国华, 黄薇 . 二甲双胍在多囊卵巢综合征的应用[J]. 实用妇产科杂志, 2005,21(9):534-536
doi: 10.3969/j.issn.1003-6946.2005.09.009
[12] Sharpless JL . Polycystic ovary syndrome and the metabolic syndrome[J]. Clin Diabetes, 2001,21(4):154-161
doi: 10.3109/9780849379581.036 pmid: 21213522
[13] Xia ZL, Hua K . The role of metformin in polycystic ovary syndrome[J]. Guo Wai Yi Xue Fu Chan Ke Xue Fen Ce, 2004,31(2):73-76
夏舟岚, 华凯 . 二甲双胍在多囊卵巢综合征中的作用[J]. 国外医学妇产科学分册, 2004,31(2):73-76
[14] Zhang MY, Li GG, Cai HD, Zeng QR, Yang YS, Li MS, Song YK. Infertility and reproductive endocrinology(2nd ed)[M]. Beijing: Peking University Medical Press, 2005,( 2nd ed):97-102
张明扬, 李国光, 蔡鸿德, 曾启瑞, 杨友仕, 李茂盛, 宋勇奎 . 不孕症及生殖内分泌学(第2版)[M]. 北京: 北京大学医学出版社, 2005,( 第2版):97-102
[15] Han XM, Jiang K . Clinical observation of 35 cases of polycystic ovary syndrome treated with Diane-35[J]. Zhi Ye Yu Jian Kang, 2007,23(23):2222
doi: 10.3969/j.issn.1672-3422.2007.21.040
韩雪梅, 姜坤 . 达英-35治疗多囊卵巢综合征30例临床观察[J]. 职业与健康, 2007,23(23):2222
doi: 10.3969/j.issn.1672-3422.2007.21.040
[16] Livingstone C, Collison M . Sex steroids and insulin resistance[J]. Clin Sci (Lond), 2002,102(2):151-166
doi: 10.1042/CS20010197 pmid: 11834135
[1] Sherman Gu, Arthur Yin Fan. Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support. Journal of Integrative Medicine, 2020, 18(2): 89-91.
[2] Sonia Chew Wen Phang, Uma Devi Palanisamy, Khalid Abdul Kadir. Effects of geraniin (rambutan rind extract) on blood pressure and metabolic parameters in rats fed high-fat diet. Journal of Integrative Medicine, 2019, 17(2): 100-106.
[3] Mehranghiz Ebrahimi-Mameghani, Mohammad Asghari-Jafarabadi, Khatereh Rezazadeh. TCF7L2-rs7903146 polymorphism modulates the effect of artichoke leaf extract supplementation on insulin resistance in metabolic syndrome: A randomized, double-blind, placebo-controlled trial. Journal of Integrative Medicine, 2018, 16(5): 329-334.
[4] Qian-wen Ma, Yong Tan. Effectiveness of co-treatment with traditional Chinese medicine and letrozole for polycystic ovary syndrome: A meta-analysis. Journal of Integrative Medicine, 2017, 15(2): 95-101.
[5] Jin Yu, Chao-qin Yu, Qi Cao, Li Wang, Wen-jun Wang, Li-rong Zhou, Jing Li, Qiao-hong Qian. Consensus on the integrated traditional Chinese and Western medicine criteria of diagnostic classification in polycystic ovary syndrome (draft). Journal of Integrative Medicine, 2017, 15(2): 102-109.
[6] Nazli Samadi, Hassan Mozaffari-Khosravi, Masoud Rahmanian, Mohsen Askarishahi. Effects of bee propolis supplementation on glycemic control, lipid profile and insulin resistance indices in patients with type 2 diabetes: A randomized, double-blind clinical trial. Journal of Integrative Medicine, 2017, 15(2): 124-134.
[7] Maria T.Chao, AlexandraChang, SanjayReddy, James D.Harrison, JosephAcquah, MiriaToveg, TrilceSantana, Frederick M.Hecht. Adjunctive acupuncture for pain and symptom management in the inpatient setting: Protocol for a pilot hybrid effectiveness-implementation study. Journal of Integrative Medicine, 2016, 14(3): 228-238.
[8] Nouran A. Aleyeidi, Khaled S. Aseri, Shadia M. Matbouli, Albaraa A. Sulaiamani, Sumayyah A. Kobeisy. Effects of wet-cupping on blood pressure in hypertensive patients: A randomized controlled trial. Journal of Integrative Medicine, 2015, 13(6): 391-399.
[9] Zhong-liang Liu, Wei-rong Zhu, Wen-chao Zhou, Hai-feng Ying, Lan Zheng, Yuan-biao Guo, Jing-xian Chen, Xiao-heng Shen. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: A systematic review and meta-analysis. Journal of Integrative Medicine, 2014, 12(4): 346-358.
[10] Zhi-yi Zhou, Ling Xu, He-gen Li, Jian-hui Tian, Li-jing Jiao, Sheng-fu You, Zhi-fen Han, Yi Jiang, Hui-ru Guo​, Hui Liu​. Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: Protocol for a randomized double-blind controlled trial. Journal of Integrative Medicine, 2014, 12(3): 175-181.
[11] Dagmar Ehling. Integrative techniques using acupuncture, Chinese herbal medicine, diet, and supplements for polycystic ovary syndrome: A case report. Journal of Chinese Integrative Medicine, 2013, 11(6): 422-427.
[12] Jian Liu, Chuan-bing Huang, Yuan Wang, Gui-qin Xu, Yuan-yuan Cheng, Yun-xia Feng, Lei Liu, Ya-jun Qi. Chinese herbal medicine Xinfeng Capsule in treatment of rheumatoid arthritis: Study protocol of a multicenter randomized controlled trial. Journal of Chinese Integrative Medicine, 2013, 11(6): 428-434.
[13] Wen-jian Wang. Enhancing the treatment of metabolic syndrome with integrative medicine. Journal of Chinese Integrative Medicine, 2013, 11(3): 153-156.
[14] Tian-zhan Wang, Yu Chen, Yan-ming He, Xiao-dong Fu, Wang Yi, Yan-qiu Xu, Hong-jie Yang, Hong-li Xue, Yi Liu, Xiao-tao Feng, Teng Zhang, Wen-jian Wang. Effects of Chinese herbal medicine Yiqi Huaju Qingli Formula in metabolic syndrome patients with microalbuminuria: a randomized placebo-controlled trial. Journal of Chinese Integrative Medicine, 2013, 11(3): 175-183.
[15] Chung-wah Cheng, Shu-fei Fu, Qing-hui Zhou, Tai-xiang Wu, Hong-cai Shang, Xu-dong Tang, Zhi-shun Liu, Jia Liu, Zhi-xiu Lin, Lixing Lao, Ai-ping Lü, Bo-li Zhang, Bao-yan Liu, Zhao-xiang Bian. Extending the CONSORT Statement to moxibustion. Journal of Chinese Integrative Medicine, 2013, 11(1): 54-63.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[2] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[3] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[4] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[5] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[6] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[7] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[8] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[9] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[10] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022